Literature DB >> 1655355

Retinitis in euthymic mice following inoculation of murine cytomegalovirus (MCMV) via the supraciliary route.

S S Atherton1, C K Newell, M Y Kanter, S W Cousins.   

Abstract

Cytomegalovirus (CMV) retinitis is the most frequent infectious ocular complication of the acquired immune deficiency syndrome (AIDS). Currently, there are few animal models to study the virologic and immunologic factors which contribute to the pathogenesis of CMV retinitis. In these experiments, 1-2 X 10(4) PFU of murine cytomegalovirus (MCMV) was inoculated into the supraciliary space of BALB/c mice. Within three days of inoculation, moderate iridocyclitis was observed which progressed to necrosis of the ciliary body by day 14. Approximately 60% of the mice developed typical retinitis characterized by virus-infected cytomegalic cells in the retina and retinal pigment epithelium, focal retinal infiltrates, transition zones between uninvolved and involved retina, and optic neuritis. The remaining animals exhibited atypical retinitis characterized by non-specific retinal inflammation in the absence of obvious viral infection. This murine model of CMV retinitis shares some features with retinitis observed in AIDS patients with CMV retinitis and may be useful to evaluate the efficacy of immunologic and/or pharmacologic treatment strategies for CMV retinitis.

Entities:  

Mesh:

Year:  1991        PMID: 1655355     DOI: 10.3109/02713689109013858

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  11 in total

1.  Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis.

Authors:  Emily L Blalock; Hsin Chien; Richard D Dix
Journal:  Cytokine       Date:  2013-02-14       Impact factor: 3.861

2.  Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Rebecca Rosenke; James F Striebel; Bruce Chesebro
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

3.  Murine cytomegalovirus (MCMV) spreads to and replicates in the retina after endotoxin-induced disruption of the blood-retinal barrier of immunosuppressed BALB/c mice.

Authors:  Ming Zhang; Hua Xin; Sally S Atherton
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

4.  Loss of the perforin cytotoxic pathway predisposes mice to experimental cytomegalovirus retinitis.

Authors:  Richard D Dix; Eckhard R Podack; Scott W Cousins
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Immunosuppression induces transcription of murine cytomegalovirus glycoprotein H in the eye and at non-ocular sites.

Authors:  Y Duan; S S Atherton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Evidence for multiple cell death pathways during development of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression: apoptosis, necroptosis, and pyroptosis.

Authors:  Hsin Chien; Richard D Dix
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

7.  Persisting murine cytomegalovirus can reactivate and has unique transcriptional activity in ocular tissue.

Authors:  Lisa Kercher; Bradley M Mitchell
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 8.  SOCS and Herpesviruses, With Emphasis on Cytomegalovirus Retinitis.

Authors:  Christine I Alston; Richard D Dix
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

9.  Susceptibility of human retinal pigment epithelial cells to different viruses.

Authors:  H P Huemer; C Larcher; W Kirchebner; J Klingenschmid; W Göttinger; E U Irschick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

10.  Atypical cytomegalovirus retinal disease in pyroptosis-deficient mice with murine acquired immunodeficiency syndrome.

Authors:  Jessica J Carter; Judee Grace E Nemeno; Jay J Oh; John E Houghton; Richard D Dix
Journal:  Exp Eye Res       Date:  2021-06-05       Impact factor: 3.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.